Insider Trading / SAST

Omkar Pharmachem has announced a closure of its trading window for designated persons and their immediate relatives starting from July 1, 2025, until 48 hours after the announcement of the financial results for the quarter ended June 30, 2025. This step aligns with the company’s internal code of conduct to prevent insider trading around sensitive financial disclosures.

The date for the board meeting to approve the quarter's financial results will be communicated later.

This affects trading activity for insiders ahead of key financial updates.